Regulatory News
Monday, April 18, 2016
BRIEF-Dynavax presents encouraging data from clinical trial of immuno-oncology product candidate, SD-101
* Dynavax presents encouraging data from clinical trial of
immuno-oncology product candidate, SD-101
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment